newsfilter
← Latest News
PR Newswire·

Rigel Provides Business Update and 2026 Outlook

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today provided a...